The Kathmandu Post on MSN
DDA took 11 months to test substandard drug. Patients may have already taken it
The Department of Drug Administration (DDA) has recalled a third-generation antibiotic, Levoflox-500 tablet, after the ...
The Kathmandu Post on MSN
Over 24,000 medicines are in Nepal’s market, only 648 tested last year
Of the more than 24,000 types of medicines—both allopathic and ayurvedic—available in the Nepali market and manufactured by ...
All samples met Indian Pharmacopeia standards for drug content, dissolution, and impurities, with no meaningful quality ...
A citizen-funded quality study of commonly prescribed medicines has found no difference in quality between expensive branded ...
A crowdfunded study found that all 131 drugs tested met all quality standards. This contradicts even the official data on ...
News-Medical.Net on MSN
A pill that confirms you actually swallowed your medicine
SAFARI capsule technology offers a novel solution for medication adherence, using a dissolvable Faraday cage to verify ...
The Kathmandu Post on MSN
DDA recalls Nepali antibiotic over quality concerns
The Department of Drug Administration (DDA) has recalled a third-generation antibiotic, Levoflox-500 tablet, after the ...
A deep-dive into what's driving the shift toward seawater-derived electrolytes-and how Seaonic's published disclosures ...
6hon MSN
Bob Weir’s Cosmic Touch
The inimitable Bobby Ace played guitar alongside Jerry Garcia for over three decades. His unique style and merry personality ...
NDTV Profit on MSNOpinion
Study Finds No Quality Gap Between Branded And Generic Drugs; Why Pay 14x More? Says 'TheLiverDoc'
Government-run Jan Aushadhi stores emerged as the clear winner, offering the lowest prices for 82% of medicines tested.
Generic drugs are supposed to be equivalent to brand-name medications — but the FDA doesn’t always ensure that.
Dealbreaker on MSN
Sobi grows its gout drug prospects with $950M acquisition of startup Arthrosi Therapeutics
Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results